Inhibition of IP6K1 suppresses neutrophil-mediated pulmonary damage in bacterial pneumonia
Year: 2018
Type: article
Abstract: -nitrobenzyl)purine] efficiently and effectively enhanced host bacterial killing but reduced pulmonary neutrophil accumulation, minimizing the lung damage caused by both Gram-positive and Gram-negative bacterial pneumonia. IP6K1-mediated inorganic polyphosphate (polyP) production by platelets was essential for infection-induced neutrophil-platelet aggregate (NPA) formation and facilitated neutrophil accumulation in alveolar spaces during bacterial pneumonia. IP6K1 inhibition reduced serum polyP levels, which regulated NPAs by triggering the bradykinin pathway and bradykinin-mediated neutrophil activation. Thus, we identified a mechanism that enhances host defenses while simultaneously suppressing neutrophil-mediated pulmonary damage in bacterial pneumonia. IP6K1 is, therefore, a legitimate therapeutic target for such disease.
Source: Science Translational Medicine
Institutions: Boston Children's Hospital, Harvard University, Dana-Farber/Harvard Cancer Center, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, State Key Laboratory of Experimental Hematology, Johns Hopkins University, VA Boston Healthcare System, Emory University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: Enhancing neutrophil function in neutropenia-related pneumonia, Signal transduction in neutrophil chemotaxis, Regulation of neutrophil function by ROS-induced actin glutathionylation, Molecular Mechanisms of Blood Cell Transfusion, Inositol hexakisphosphate kinase-1 As a Novel Target in Obesity, HTS for enhancers of neutrophil function that specifically augment PIP3 signal
OpenAlex ID: W2795418924
